These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 596455)

  • 1. Sodium retention and ascites formation in dogs with experimental portal cirrhosis.
    Levy M
    Am J Physiol; 1977 Dec; 233(6):F572-85. PubMed ID: 596455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.
    Levy M; Wexler MJ
    Am J Physiol; 1987 Oct; 253(4 Pt 2):F664-71. PubMed ID: 3661718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites.
    Unikowsky B; Wexler MJ; Levy M
    J Clin Invest; 1983 Nov; 72(5):1594-604. PubMed ID: 6630520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms.
    Levy M
    Am J Physiol; 1977 Dec; 233(6):F586-92. PubMed ID: 596456
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
    Domenicali M; Caraceni P; Giannone F; Pertosa AM; Principe A; Zambruni A; Trevisani F; Croci T; Bernardi M
    Gastroenterology; 2009 Jul; 137(1):341-9. PubMed ID: 19208344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.
    Lieberman FL; Ito S; Reynolds TB
    J Clin Invest; 1969 Jun; 48(6):975-81. PubMed ID: 5771197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis.
    Levy M; Allotey JB
    J Lab Clin Med; 1978 Oct; 92(4):560-9. PubMed ID: 712196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
    Schrier RW; Arroyo V; Bernardi M; Epstein M; Henriksen JH; Rodés J
    Hepatology; 1988; 8(5):1151-7. PubMed ID: 2971015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of ascites formation in rats with experimental cirrhosis.
    López-Novoa JM; Rengel MA; Hernando L
    Am J Physiol; 1980 May; 238(5):F353-7. PubMed ID: 7377346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of ascites formation in cirrhosis of the liver.
    Gerbes AL
    Hepatogastroenterology; 1991 Oct; 38(5):360-4. PubMed ID: 1765351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of ascites formation.
    Dudley FJ
    Gastroenterol Clin North Am; 1992 Mar; 21(1):215-35. PubMed ID: 1568774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of sodium retention and ascites formation in cirrhosis.
    Arroyo V; Ginès P
    J Hepatol; 1993; 17 Suppl 2():S24-8. PubMed ID: 8491967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis.
    Levy M; Richard C
    Am J Physiol; 1978 Jul; 235(1):F12-21. PubMed ID: 677315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal sodium handling in cirrhosis: a reappraisal.
    Epstein M
    Nephron; 1979; 23(5):211-7. PubMed ID: 384279
    [No Abstract]   [Full Text] [Related]  

  • 20. Pressure diuresis and natriuresis in cirrhotic rats.
    Atucha NM; Cegarra M; Ramirez A; Quesada T; Garcia-Estañ J
    Am J Physiol; 1993 Dec; 265(6 Pt 1):G1045-9. PubMed ID: 8279554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.